Drug Development Archives - Oncology Central Oncology Central

i
i

25 Apr 2019 News
One in 10 cancer patients denied drugs recommended by their doctor, study finds
2 Apr 2019 Pancreatic
AACR19: rucaparib produces clinical response in certain pancreatic cancer patients
1 Apr 2019 News
AACR19: LOXO-195 shows promise as therapy for tumors with acquired NTRK resistance
8 Mar 2019 Ask the Experts
An interview with V. Craig Jordan: breast cancer, SERMs, tamoxifen
26 Feb 2019 Pancreatic
Lynparza® significantly delays disease progression in late-stage pancreatic cancer
20 Feb 2019 News
Pembrolizumab fails to meet primary endpoint in KEYNOTE-240 liver cancer trial
7 Feb 2019 Clinical trials
Isatuximab meets primary endpoint in Phase III multiple myeloma trial
1 Feb 2019 CAR-T therapy
NICE approves CAR-T therapy Kymriah® for diffuse large B-cell lymphoma in adults
22 Jan 2019 Targeted therapies
Future Oncology: best of 2018
15 Jan 2019 Clinical trials
The CLEAR study: design and rationale of the Phase III trial comparing RCC first-line treatment
15 Jan 2019 Gastrointestinal
JAVELIN Gastric 100: exploring maintenance avelumab vs first-line chemotherapy in gastric cancer
9 Jan 2019 Chemotherapy
HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV